Robb Knie insider trades: Hoth Therapeutics (HOTH) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robb reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | HOTH | ↑ Buy | 25,000 | $0.67 | $17K | Direct | Aug 19, 2024 (3d) |
| Sep 19, 2022 | HOTH | ↑ Buy | 10,000 | $0.39 | $4K | Direct | Sep 20, 2022 (1d) |
| Sep 16, 2022 | HOTH | ↑ Buy | 10,000 | $0.40 | $4K | Direct | Sep 19, 2022 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robb Knie's insider trades
Robb Knie is CEO and President at Hoth Therapeutics (HOTH). Since Sep 16, 2022, Robb has reported 3 open-market purchases worth $25K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), shares withheld for taxes (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HOTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.